Raymond M Reilly

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 29

Top Topics

Computed Tomography

Positive Breast Cancer

Tyrosine Kinase

Top Venues

Molecular pharmaceutics

EJNMMI radiopharmacy and chemistry

Biomacromolecules

International journal of radiation biology

This page only lists publications with an associated author ORCID identifier.

Publications

Raymond M Reilly, Constantine J Georgiou, Madeline K Brown, Zhongli Cai
Radiation nanomedicines for cancer treatment: a scientific journey and view of the landscape. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Raymond M Reilly, Constantine J Georgiou, Madeline K Brown, Zhongli Cai
Radiation nanomedicines for cancer treatment: a scientific journey and view of the landscape. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Valerie J Facca, Zhongli Cai, Anthony Ku, Constantine J Georgiou, Raymond M Reilly
Adjuvant Auger Electron-Emitting Radioimmunotherapy with [ 111 In]In-DOTA-Panitumumab in a Mouse Model of Local Recurrence and Metastatic Progression of Human Triple-Negative Breast Cancer. Molecular pharmaceutics (2023)
Misaki Kondo, Zhongli Cai, Conrad Chan, Nubaira Forkan, Raymond M Reilly
[ 225 Ac]Ac- and [ 111 In]In-DOTA-trastuzumab theranostic pair: cellular dosimetry and cytotoxicity in vitro and tumour and normal tissue uptake in vivo in NRG mice with HER2-positive human breast cancer xenografts. EJNMMI radiopharmacy and chemistry 8 (1) (2023)
Zhongli Cai, Rella Liu, Conrad Chan, Yijie Lu, Mitchell A Winnik, David W Cescon, Raymond M Reilly
90 Y-Labeled Gold Nanoparticle Depot (NPD) Combined with Anti-PD-L1 Antibodies Strongly Inhibits the Growth of 4T1 Tumors in Immunocompetent Mice and Induces an Abscopal Effect on a Distant Non-Irradiated Tumor. Molecular pharmaceutics 19 (11) (2022)
Conrad Chan, Vanessa Prozzo, Sadaf Aghevlian, Raymond M Reilly
Formulation of a kit under Good Manufacturing Practices (GMP) for preparing [ 111 In]In-BnDTPA-trastuzumab-NLS injection: a theranostic agent for imaging and Meitner-Auger Electron (MAE) radioimmunotherapy of HER2-positive breast cancer. EJNMMI radiopharmacy and chemistry 7 (1) (2022)
Conrad Chan, Vanessa Prozzo, Sadaf Aghevlian, Raymond M Reilly
Formulation of a kit under Good Manufacturing Practices (GMP) for preparing [ 111 In]In-BnDTPA-trastuzumab-NLS injection: a theranostic agent for imaging and Meitner-Auger Electron (MAE) radioimmunotherapy of HER2-positive breast cancer. EJNMMI radiopharmacy and chemistry 7 (1) (2022)
Constantine J Georgiou, Zhongli Cai, Noor Alsaden, Hyungjun Cho, Minou Behboudi, Mitchell A Winnik, James T Rutka, Raymond M Reilly
Treatment of Orthotopic U251 Human Glioblastoma Multiforme Tumors in NRG Mice by Convection-Enhanced Delivery of Gold Nanoparticles Labeled with the β-Particle-Emitting Radionuclide, 177 Lu. Molecular pharmaceutics 20 (1) (2022)
Conrad Chan, Vanessa Prozzo, Sadaf Aghevlian, Raymond M Reilly
Formulation of a kit under Good Manufacturing Practices (GMP) for preparing [ 111 In]In-BnDTPA-trastuzumab-NLS injection: a theranostic agent for imaging and Meitner-Auger Electron (MAE) radioimmunotherapy of HER2-positive breast cancer. EJNMMI radiopharmacy and chemistry 7 (1) (2022)
Conrad Chan, Vanessa Prozzo, Sadaf Aghevlian, Raymond M Reilly
Formulation of a kit under Good Manufacturing Practices (GMP) for preparing [ 111 In]In-BnDTPA-trastuzumab-NLS injection: a theranostic agent for imaging and Meitner-Auger Electron (MAE) radioimmunotherapy of HER2-positive breast cancer. EJNMMI radiopharmacy and chemistry 7 (1) (2022)
Megan G Roberts, Valerie J Facca, Rachel Keunen, Qing Yu, Raymond M Reilly, Mitchell A Winnik
Changing Surface Polyethylene Glycol Architecture Affects Elongated Nanoparticle Penetration into Multicellular Tumor Spheroids. Biomacromolecules 23 (8) (2022)
Constantine J Georgiou, Zhongli Cai, Noor Alsaden, Hyungjun Cho, Minou Behboudi, Mitchell A Winnik, James T Rutka, Raymond M Reilly
Treatment of Orthotopic U251 Human Glioblastoma Multiforme Tumors in NRG Mice by Convection-Enhanced Delivery of Gold Nanoparticles Labeled with the β-Particle-Emitting Radionuclide, 177 Lu. Molecular pharmaceutics 20 (1) (2022)
Constantine J Georgiou, Zhongli Cai, Noor Alsaden, Hyungjun Cho, Minou Behboudi, Mitchell A Winnik, James T Rutka, Raymond M Reilly
Treatment of Orthotopic U251 Human Glioblastoma Multiforme Tumors in NRG Mice by Convection-Enhanced Delivery of Gold Nanoparticles Labeled with the β-Particle-Emitting Radionuclide, 177 Lu. Molecular pharmaceutics 20 (1) (2022)
Constantine J Georgiou, Zhongli Cai, Noor Alsaden, Hyungjun Cho, Minou Behboudi, Mitchell A Winnik, James T Rutka, Raymond M Reilly
Treatment of Orthotopic U251 Human Glioblastoma Multiforme Tumors in NRG Mice by Convection-Enhanced Delivery of Gold Nanoparticles Labeled with the β-Particle-Emitting Radionuclide, 177 Lu. Molecular pharmaceutics 20 (1) (2022)
Constantine J Georgiou, Zhongli Cai, Noor Alsaden, Hyungjun Cho, Minou Behboudi, Mitchell A Winnik, James T Rutka, Raymond M Reilly
Treatment of Orthotopic U251 Human Glioblastoma Multiforme Tumors in NRG Mice by Convection-Enhanced Delivery of Gold Nanoparticles Labeled with the β-Particle-Emitting Radionuclide, 177 Lu. Molecular pharmaceutics (2022)
Valerie J Facca, Zhongli Cai, Nakita E K Gopal, Raymond M Reilly
Panitumumab-DOTA- 111 In: An Epidermal Growth Factor Receptor Targeted Theranostic for SPECT/CT Imaging and Meitner-Auger Electron Radioimmunotherapy of Triple-Negative Breast Cancer. Molecular pharmaceutics 19 (10) (2022)
Valerie J Facca, Noor Al-Saden, Anthony Ku, Raymond M Reilly
Imaging of HER2-Positive Tumors in NOD/SCID Mice with Pertuzumab Fab-Hexahistidine Peptide Immunoconjugates Labeled with [99mTc]-(I)-Tricarbonyl Complex. Molecular imaging and biology 23 (4) (2021)
Ying Meng, Raymond M Reilly, Rossanna C Pezo, Maureen Trudeau, Arjun Sahgal, Amit Singnurkar, James Perry, Sten Myrehaug, Christopher B Pople, Benjamin Davidson, Maheleth Llinas, Chinthaka Hyen, Yuexi Huang, Clement Hamani, Suganth Suppiah, Kullervo Hynynen, Nir Lipsman
MR-guided focused ultrasound enhances delivery of trastuzumab to Her2-positive brain metastases. Science translational medicine 13 (615) (2021)
Penny J Le, Shane Miersch, Matthew W Forbes, Nick Jarvik, Anthony Ku, Sachdev S Sidhu, Raymond M Reilly, Mitchell A Winnik
Site-Specific Conjugation of Metal-Chelating Polymers to Anti-Frizzled-2 Antibodies via Microbial Transglutaminase. Biomacromolecules 22 (6) (2021)
Simmyung Yook, Zhongli Cai, Jenny Jooyoung Jeong, Yijie Lu, Mitchell A Winnik, Jean-Philippe Pignol, Raymond M Reilly
Dual-Receptor-Targeted (DRT) Radiation Nanomedicine Labeled with 177Lu Is More Potent for Killing Human Breast Cancer Cells That Coexpress HER2 and EGFR Than Single-Receptor-Targeted (SRT) Radiation Nanomedicines. Molecular pharmaceutics 17 (4) (2020)
Zhongli Cai, Noor Al-Saden, Constantine J Georgiou, Raymond M Reilly
Cellular dosimetry of 197Hg, 197mHg and 111In: comparison of dose deposition and identification of the cell and nuclear membrane as important targets. International journal of radiation biology (2020)
Megan G Roberts, Qing Yu, Rachel Keunen, Jieyi Liu, Edmond Chi Ngae Wong, Chandresh Kumar Rastogi, Raymond M Reilly, Christine Allen, Mitchell A Winnik
Functionalization of Cellulose Nanocrystals with POEGMA Copolymers via Copper-Catalyzed Azide-Alkyne Cycloaddition for Potential Drug-Delivery Applications. Biomacromolecules 21 (6) (2020)
Sadaf Aghevlian, Zhongli Cai, David Hedley, Mitchell A Winnik, Raymond M Reilly
Radioimmunotherapy of PANC-1 human pancreatic cancer xenografts in NOD/SCID or NRG mice with Panitumumab labeled with Auger electron emitting, 111In or β-particle emitting, 177Lu. EJNMMI radiopharmacy and chemistry 5 (1) (2020)
Anthony Ku, Conrad Chan, Sadaf Aghevlian, Zhongli Cai, David Cescon, Scott V Bratman, Laurie Ailles, David W Hedley, Raymond M Reilly
MicroSPECT/CT Imaging of Cell-Line and Patient-Derived EGFR-Positive Tumor Xenografts in Mice with Panitumumab Fab Modified with Hexahistidine Peptides To Enable Labeling with 99mTc(I) Tricarbonyl Complex. Molecular pharmaceutics 16 (8) (2019)
Sadaf Aghevlian, Zhongli Cai, Yijie Lu, David W Hedley, Mitchell A Winnik, Raymond M Reilly
Radioimmunotherapy of PANC-1 Human Pancreatic Cancer Xenografts in NRG Mice with Panitumumab Modified with Metal-Chelating Polymers Complexed to 177Lu. Molecular pharmaceutics 16 (2) (2019)
Noor Al-Saden, Karen Lam, Conrad Chan, Raymond M Reilly
Positron-Emission Tomography of HER2-Positive Breast Cancer Xenografts in Mice with 89Zr-Labeled Trastuzumab-DM1: A Comparison with 89Zr-Labeled Trastuzumab. Molecular pharmaceutics 15 (8) (2018)
Sadaf Aghevlian, Yijie Lu, Mitchell A Winnik, David W Hedley, Raymond M Reilly
Panitumumab Modified with Metal-Chelating Polymers (MCP) Complexed to 111In and 177Lu-An EGFR-Targeted Theranostic for Pancreatic Cancer. Molecular pharmaceutics 15 (3) (2018)
Yijie Lu, Amanda J Boyle, Ping-Jiang Cao, David Hedley, Raymond M Reilly, Mitchell A Winnik
EGFR-Targeted Metal Chelating Polymers (MCPs) Harboring Multiple Pendant PEG2K Chains for MicroPET/CT Imaging of Patient-Derived Pancreatic Cancer Xenografts. ACS biomaterials science & engineering 3 (3) (2017)
Luke Yongkyu Kwon, Deborah A Scollard, Raymond M Reilly
64Cu-Labeled Trastuzumab Fab-PEG24-EGF Radioimmunoconjugates Bispecific for HER2 and EGFR: Pharmacokinetics, Biodistribution, and Tumor Imaging by PET in Comparison to Monospecific Agents. Molecular pharmaceutics 14 (2) (2017)